Tian Jing, Lv Rong, Guo Wei
Department of Pathology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):8-14. doi: 10.19540/j.cnki.cjcmm.20171027.014.
Diabetic cardiomyopathy (DCM) is characterized by left ventricular hypertrophy, myocardial fibrosis and diastolic dysfunction, which are uncorrelated with underlying coronary artery disease or hypertension. As an important metabolic organelle, mitochondria directly involve the process of cell growth, proliferation, signal transduction, apoptosis and so on. Recent studies have demonstrated a close correlation between the mitochondrial dysfunction and the pathogenesis of diabetic cardiomyopathy. The underlying effects of mitochondrial dysfunction in the progress of diabetic cardiomyopathy involve disturbed metabolism, oxidative stress, defective calcium handling, mitochondrial uncoupling, apoptosis, imbalance of mitochondrial quality control and regulation of MicroRNAs. Traditional Chinese medicines have been widely applied in clinic. Nowadays, more and more herbs of extracts of traditional Chinese medicines have been proved to ameliorate diabetic myocardial injury. Because the improvement of mitochondrial dysfunction has emerged as a promising therapeutic strategy, this review summarizes these effects of mitochondrial dysfunction in diabetic cardiomyopathy, and discusses the intervention studies of traditional Chinese medicine in the field, in expectation to provide new ideas for DCM prevention and treatment.
糖尿病性心肌病(DCM)的特征是左心室肥厚、心肌纤维化和舒张功能障碍,这些与潜在的冠状动脉疾病或高血压无关。作为重要的代谢细胞器,线粒体直接参与细胞生长、增殖、信号转导、凋亡等过程。最近的研究表明,线粒体功能障碍与糖尿病性心肌病的发病机制密切相关。线粒体功能障碍在糖尿病性心肌病进展中的潜在影响包括代谢紊乱、氧化应激、钙处理缺陷、线粒体解偶联、凋亡、线粒体质量控制失衡以及微小RNA的调节。中药已在临床上广泛应用。如今,越来越多的中药提取物已被证明可改善糖尿病心肌损伤。由于改善线粒体功能障碍已成为一种有前景的治疗策略,本综述总结了线粒体功能障碍在糖尿病性心肌病中的这些作用,并讨论了该领域的中药干预研究,以期为DCM的预防和治疗提供新思路。